CA Patent

CA2957225A1 — Crystal forms of glutaminase inhibitors

Assigned to Calithera Biosciences Inc · Expires 2016-02-11 · 10y expired

What this patent protects

The invention relates to crystalline salts of a compound having the structure of formula (I), methods for their preparation, and related pharmaceutical compositions comprising the crystalline salt. The invention further relates to methods of treating or preventing cancer or an im…

USPTO Abstract

The invention relates to crystalline salts of a compound having the structure of formula (I), methods for their preparation, and related pharmaceutical compositions comprising the crystalline salt. The invention further relates to methods of treating or preventing cancer or an immunological or neurological disease comprising administering a crystalline salt of the invention.

Drugs covered by this patent

Patent Metadata

Patent number
CA2957225A1
Jurisdiction
CA
Classification
—
Expires
2016-02-11
Drug substance claim
No
Drug product claim
No
Assignee
Calithera Biosciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.